Effect of BRAF/MEK Inhibition on Epithelioid Glioblastoma with BRAFV600E Mutation: a Case Report and Review of the Literature.
Clin Lab
; 66(8)2020 Aug 01.
Article
in En
| MEDLINE
| ID: mdl-32776753
ABSTRACT
BACKGROUND:
To explore the effect of BRAF inhibitor on epithelioid glioblastoma (Ep-GBM) with BRAFV600E mutation.METHODS:
A patient of Ep-GBM with BRAFV600E mutation underwent BRAF inhibition therapy. The rationale behind combined BRAF and MEK inhibition in Ep-GBM was reviewed.RESULTS:
Vemurafenib can initially inhibit the progression of Ep-GBM with BRAFV600E mutation. However, the tumor may become resistant to vemurafenib and then progress.CONCLUSIONS:
BRAF inhibition therapy can inhibit the progression of Ep-GBM with BRAFV600E mutation, but the subsequent resistance development leads to a poor outcome.
Full text:
1
Database:
MEDLINE
Main subject:
Glioblastoma
/
Proto-Oncogene Proteins B-raf
Limits:
Humans
Language:
En
Year:
2020
Type:
Article